IMUGENE LIMITED - Announcements

3.64%

26.5¢

Market Cap $76.45M

Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IMU	Investor Presentation		24/03/15	10.06MB	Share
IMU	Investor Presentation		10/03/15	9.95MB	Share
IMU	Imugene to Present at 27th Annual Roth Conference		06/03/15	78.14KB	Share
IMU	Grant of Options to Dr Nick Ede & Appendix 3B		27/02/15	405.8KB	Share
IMU	Appendix 4D - Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/15	809.86KB	Share
IMU	Summary of Half Year results		27/02/15	58.75KB	Share
IMU	Response to Price Query	PRICE SENSITIVE	20/02/15	216.08KB	Share
IMU	Imugene Receives $230K Research and Development Tax Refund	PRICE SENSITIVE	18/02/15	57.21KB	Share
IMU	Investor Presentation		10/02/15	3.04MB	Share
IMU	Initial Director's Interest Notice		02/02/15	102.34KB	Share
IMU	Appointment of Charles Walker as Managing Director	PRICE SENSITIVE	02/02/15	51.96KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/15	152.73KB	Share
IMU	Investor Presentation		13/01/15	4.01MB	Share
IMU	Appendix 3B		06/01/15	388.55KB	Share
IMU	New milestones in preparation for HER-Vaxx clinical trial	PRICE SENSITIVE	30/12/14	68.18KB	Share
IMU	Notice under section 708A of the Corporations Act		18/12/14	67.63KB	Share
IMU	Ceasing to be a substantial holder		16/12/14	814.12KB	Share
IMU	Ceasing to be a substantial holder		16/12/14	677.92KB	Share
IMU	Change in substantial holding		16/12/14	310.64KB	Share
IMU	Ceasing to be a substantial holder		16/12/14	61.5KB	Share
IMU	Change of Director's Interest Notice (PH)		16/12/14	139.38KB	Share
IMU	Change of Director's Interest Notice (OB)		16/12/14	140.13KB	Share
IMU	Completion of share purchase plan allotment		16/12/14	44.55KB	Share
IMU	Appendix 3B		15/12/14	346.95KB	Share
IMU	Further placement & close of SPP raising over $3.5m in total	PRICE SENSITIVE	09/12/14	65.49KB	Share
IMU	Release of Shares from Escrow		05/12/14	44.04KB	Share
IMU	New Research Note available from Edison Investment Research		04/12/14	60.1KB	Share
IMU	HER-Vaxx peptides demonstrate high level of activity	PRICE SENSITIVE	01/12/14	73.12KB	Share
IMU	Publication of Research Note		28/11/14	58.66KB	Share
IMU	Imugene to divest Linguet drug delivery technology	PRICE SENSITIVE	28/11/14	64.48KB	Share
IMU	Extension of Share Purchase Plan Closing Date		27/11/14	47.92KB	Share
IMU	Results of Meeting		25/11/14	62.41KB	Share
IMU	AGM 2014 Presentation		25/11/14	1.92MB	Share
IMU	Placement Cleansing Notice		13/11/14	67.06KB	Share
IMU	Additional placement details		12/11/14	59.38KB	Share
IMU	Appendix 3B		12/11/14	308.61KB	Share
IMU	Share Purchase Plan Offer Document & Cleansing Notice		07/11/14	663.48KB	Share
IMU	Correction to Record Date of Share Purchase Plan		05/11/14	44.67KB	Share
IMU	Capital raising for clinical development of HER-Vaxx	PRICE SENSITIVE	05/11/14	79.82KB	Share
IMU	Share Purchase Plan Cleansing Notice		05/11/14	63.67KB	Share
IMU	Investor Presentation		05/11/14	3.69MB	Share
IMU	Trading Halt	PRICE SENSITIVE	03/11/14	163.68KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14	178.02KB	Share
IMU	Notice of Annual General Meeting/Proxy Form		24/10/14	272.04KB	Share
IMU	Annual Report to shareholders		24/10/14	1.49MB	Share
IMU	Resignation of Director		23/10/14	248.15KB	Share
IMU	Investor Presentation		21/10/14	3.28MB	Share
IMU	Imugene HER-Vaxx patent granted in US	PRICE SENSITIVE	08/10/14	104.95KB	Share
IMU	Investor Presentation		16/09/14	3.52MB	Share
IMU	Swiss Drug Manufacturer to Speed Her-Vaxx Development	PRICE SENSITIVE	15/09/14	94.26KB	Share
IMU	Research Agreement with Medical University of Vienna	PRICE SENSITIVE	08/09/14	58.5KB	Share
IMU	Appendix 4E and Annual Financial Report	PRICE SENSITIVE	28/08/14	987.16KB	Share
IMU	Investor Newsletter		28/08/14	912.33KB	Share
IMU	Charles Walker appointed Imugene CEO	PRICE SENSITIVE	26/08/14	124.5KB	Share
IMU	HER-Vaxx patent application receives US Notice of Allowance	PRICE SENSITIVE	29/07/14	106.17KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	25/07/14	171.12KB	Share
IMU	Mymetics Engaged to Manufacture HER-Vaxx	PRICE SENSITIVE	16/07/14	198.68KB	Share
IMU	Initial Director's Interest Notice		08/07/14	37.21KB	Share
IMU	Otto Buttula appointed Non-Executive Director		07/07/14	53.54KB	Share
IMU	Investor Update		11/06/14	3.08MB	Share
IMU	Imugene Commences Manufacture of its Gastric Cancer Vaccine	PRICE SENSITIVE	27/05/14	194.51KB	Share
IMU	Change in substantial holding		05/05/14	733.63KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/14	152.97KB	Share
IMU	Gastric cancer specialist joins Imugene SAB		23/04/14	124.72KB	Share
IMU	Change of Director's Interest Notice (NE)		17/04/14	51.88KB	Share
IMU	Imugene Allowed Israel Patent for Cancer Vaccine	PRICE SENSITIVE	24/03/14	141.35KB	Share
IMU	IMU Commences FDA IND Process for Gastric Cancer vaccine	PRICE SENSITIVE	17/03/14	148.33KB	Share
IMU	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/14	715.65KB	Share
IMU	Imugene Investor Update		25/02/14	2.58MB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/14	159.44KB	Share
IMU	Scientific Advisory Board Appointments		20/01/14	119.44KB	Share
IMU	Change of Director's Interest Notice		24/12/13	140.6KB	Share
IMU	Becoming a substantial holder		24/12/13	940.6KB	Share
IMU	Initial Director's Interest Notice		24/12/13	85.01KB	Share
IMU	Becoming a substantial holder		23/12/13	1.24MB	Share
IMU	Change of Director's Interest Notice		23/12/13	138.02KB	Share
IMU	Final Director's Interest Notice		23/12/13	99.02KB	Share
IMU	Becoming a substantial holder		23/12/13	749.6KB	Share
IMU	Becoming a substantial holder		23/12/13	94.84KB	Share
IMU	Becoming a substantial holder		20/12/13	107.62KB	Share
IMU	Settlement of Biolife Science Qld Ltd Acquisition		20/12/13	94.05KB	Share
IMU	Appendix 3B and Section 708A Notice		20/12/13	442.09KB	Share
IMU	Results of Meeting		20/12/13	137.55KB	Share
IMU	Imugene Secures Important Intellectual Property	PRICE SENSITIVE	19/12/13	120.04KB	Share
IMU	Investor Presentation		10/12/13	6.33MB	Share
IMU	Appendix 3B and Section 708A Notice		09/12/13	436.28KB	Share
IMU	Results of Meeting		20/11/13	139.24KB	Share
IMU	AGM Presentation		20/11/13	8.05MB	Share
IMU	Notice of General Meeting/Proxy Form		18/11/13	2.23MB	Share
IMU	Appointment of Dr Axel Hoos as a Non-Executive Director		06/11/13	131.39KB	Share
IMU	Private Placement		04/11/13	112.69KB	Share
IMU	Appendix 3B & Section 708A Notice		31/10/13	438.83KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	24/10/13	162.22KB	Share
IMU	Capital Raising Complete	PRICE SENSITIVE	23/10/13	88.95KB	Share
IMU	Presentation and Q&A - Acquisition of Biolife Science Qld		23/10/13	3.81MB	Share
IMU	Imugene to acquire Biolife Science Qld Limited	PRICE SENSITIVE	23/10/13	650.74KB	Share
IMU	Trading Halt	PRICE SENSITIVE	21/10/13	235.35KB	Share
IMU	Notice of Annual General Meeting/Proxy Form		21/10/13	708.65KB	Share
IMU	Ceasing to be a substantial holder - JP		16/10/13	27.06KB	Share
IMU	Annual Report to shareholders		27/09/13	3.85MB	Share

IMU Investor Presentation
24/03/15		10.06MB	Share
IMU Investor Presentation
10/03/15		9.95MB	Share
IMU Imugene to Present at 27th Annual Roth Conference
06/03/15		78.14KB	Share
IMU Grant of Options to Dr Nick Ede & Appendix 3B
27/02/15		405.8KB	Share
IMU Appendix 4D - Half Yearly Report and Accounts
27/02/15	PRICE SENSITIVE	809.86KB	Share
IMU Summary of Half Year results
27/02/15		58.75KB	Share
IMU Response to Price Query
20/02/15	PRICE SENSITIVE	216.08KB	Share
IMU Imugene Receives $230K Research and Development Tax Refund
18/02/15	PRICE SENSITIVE	57.21KB	Share
IMU Investor Presentation
10/02/15		3.04MB	Share
IMU Initial Director's Interest Notice
02/02/15		102.34KB	Share
IMU Appointment of Charles Walker as Managing Director
02/02/15	PRICE SENSITIVE	51.96KB	Share
IMU Appendix 4C - quarterly
28/01/15	PRICE SENSITIVE	152.73KB	Share
IMU Investor Presentation
13/01/15		4.01MB	Share
IMU Appendix 3B
06/01/15		388.55KB	Share
IMU New milestones in preparation for HER-Vaxx clinical trial
30/12/14	PRICE SENSITIVE	68.18KB	Share
IMU Notice under section 708A of the Corporations Act
18/12/14		67.63KB	Share
IMU Ceasing to be a substantial holder
16/12/14		814.12KB	Share
IMU Ceasing to be a substantial holder
16/12/14		677.92KB	Share
IMU Change in substantial holding
16/12/14		310.64KB	Share
IMU Ceasing to be a substantial holder
16/12/14		61.5KB	Share
IMU Change of Director's Interest Notice (PH)
16/12/14		139.38KB	Share
IMU Change of Director's Interest Notice (OB)
16/12/14		140.13KB	Share
IMU Completion of share purchase plan allotment
16/12/14		44.55KB	Share
IMU Appendix 3B
15/12/14		346.95KB	Share
IMU Further placement & close of SPP raising over $3.5m in total
09/12/14	PRICE SENSITIVE	65.49KB	Share
IMU Release of Shares from Escrow
05/12/14		44.04KB	Share
IMU New Research Note available from Edison Investment Research
04/12/14		60.1KB	Share
IMU HER-Vaxx peptides demonstrate high level of activity
01/12/14	PRICE SENSITIVE	73.12KB	Share
IMU Publication of Research Note
28/11/14		58.66KB	Share
IMU Imugene to divest Linguet drug delivery technology
28/11/14	PRICE SENSITIVE	64.48KB	Share
IMU Extension of Share Purchase Plan Closing Date
27/11/14		47.92KB	Share
IMU Results of Meeting
25/11/14		62.41KB	Share
IMU AGM 2014 Presentation
25/11/14		1.92MB	Share
IMU Placement Cleansing Notice
13/11/14		67.06KB	Share
IMU Additional placement details
12/11/14		59.38KB	Share
IMU Appendix 3B
12/11/14		308.61KB	Share
IMU Share Purchase Plan Offer Document & Cleansing Notice
07/11/14		663.48KB	Share
IMU Correction to Record Date of Share Purchase Plan
05/11/14		44.67KB	Share
IMU Capital raising for clinical development of HER-Vaxx
05/11/14	PRICE SENSITIVE	79.82KB	Share
IMU Share Purchase Plan Cleansing Notice
05/11/14		63.67KB	Share
IMU Investor Presentation
05/11/14		3.69MB	Share
IMU Trading Halt
03/11/14	PRICE SENSITIVE	163.68KB	Share
IMU Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE	178.02KB	Share
IMU Notice of Annual General Meeting/Proxy Form
24/10/14		272.04KB	Share
IMU Annual Report to shareholders
24/10/14		1.49MB	Share
IMU Resignation of Director
23/10/14		248.15KB	Share
IMU Investor Presentation
21/10/14		3.28MB	Share
IMU Imugene HER-Vaxx patent granted in US
08/10/14	PRICE SENSITIVE	104.95KB	Share
IMU Investor Presentation
16/09/14		3.52MB	Share
IMU Swiss Drug Manufacturer to Speed Her-Vaxx Development
15/09/14	PRICE SENSITIVE	94.26KB	Share
IMU Research Agreement with Medical University of Vienna
08/09/14	PRICE SENSITIVE	58.5KB	Share
IMU Appendix 4E and Annual Financial Report
28/08/14	PRICE SENSITIVE	987.16KB	Share
IMU Investor Newsletter
28/08/14		912.33KB	Share
IMU Charles Walker appointed Imugene CEO
26/08/14	PRICE SENSITIVE	124.5KB	Share
IMU HER-Vaxx patent application receives US Notice of Allowance
29/07/14	PRICE SENSITIVE	106.17KB	Share
IMU Appendix 4C - quarterly
25/07/14	PRICE SENSITIVE	171.12KB	Share
IMU Mymetics Engaged to Manufacture HER-Vaxx
16/07/14	PRICE SENSITIVE	198.68KB	Share
IMU Initial Director's Interest Notice
08/07/14		37.21KB	Share
IMU Otto Buttula appointed Non-Executive Director
07/07/14		53.54KB	Share
IMU Investor Update
11/06/14		3.08MB	Share
IMUImugene Commences Manufacture of its Gastric Cancer Vaccine
27/05/14	PRICE SENSITIVE	194.51KB	Share
IMUChange in substantial holding
05/05/14		733.63KB	Share
IMUAppendix 4C - quarterly
23/04/14	PRICE SENSITIVE	152.97KB	Share
IMUGastric cancer specialist joins Imugene SAB
23/04/14		124.72KB	Share
IMUChange of Director's Interest Notice (NE)
17/04/14		51.88KB	Share
IMUImugene Allowed Israel Patent for Cancer Vaccine
24/03/14	PRICE SENSITIVE	141.35KB	Share
IMUIMU Commences FDA IND Process for Gastric Cancer vaccine
17/03/14	PRICE SENSITIVE	148.33KB	Share
IMUHalf Yearly Report and Accounts
27/02/14	PRICE SENSITIVE	715.65KB	Share
IMUImugene Investor Update
25/02/14		2.58MB	Share
IMUAppendix 4C - quarterly
29/01/14	PRICE SENSITIVE	159.44KB	Share
IMUScientific Advisory Board Appointments
20/01/14		119.44KB	Share
IMUChange of Director's Interest Notice
24/12/13		140.6KB	Share
IMUBecoming a substantial holder
24/12/13		940.6KB	Share
IMUInitial Director's Interest Notice
24/12/13		85.01KB	Share
IMUBecoming a substantial holder
23/12/13		1.24MB	Share
IMUChange of Director's Interest Notice
23/12/13		138.02KB	Share
IMUFinal Director's Interest Notice
23/12/13		99.02KB	Share
IMUBecoming a substantial holder
23/12/13		749.6KB	Share
IMUBecoming a substantial holder
23/12/13		94.84KB	Share
IMUBecoming a substantial holder
20/12/13		107.62KB	Share
IMUSettlement of Biolife Science Qld Ltd Acquisition
20/12/13		94.05KB	Share
IMUAppendix 3B and Section 708A Notice
20/12/13		442.09KB	Share
IMUResults of Meeting
20/12/13		137.55KB	Share
IMUImugene Secures Important Intellectual Property
19/12/13	PRICE SENSITIVE	120.04KB	Share
IMUInvestor Presentation
10/12/13		6.33MB	Share
IMUAppendix 3B and Section 708A Notice
09/12/13		436.28KB	Share
IMUResults of Meeting
20/11/13		139.24KB	Share
IMUAGM Presentation
20/11/13		8.05MB	Share
IMUNotice of General Meeting/Proxy Form
18/11/13		2.23MB	Share
IMUAppointment of Dr Axel Hoos as a Non-Executive Director
06/11/13		131.39KB	Share
IMUPrivate Placement
04/11/13		112.69KB	Share
IMUAppendix 3B & Section 708A Notice
31/10/13		438.83KB	Share
IMUAppendix 4C - quarterly
24/10/13	PRICE SENSITIVE	162.22KB	Share
IMUCapital Raising Complete
23/10/13	PRICE SENSITIVE	88.95KB	Share
IMUPresentation and Q&A - Acquisition of Biolife Science Qld
23/10/13		3.81MB	Share
IMUImugene to acquire Biolife Science Qld Limited
23/10/13	PRICE SENSITIVE	650.74KB	Share
IMUTrading Halt
21/10/13	PRICE SENSITIVE	235.35KB	Share
IMUNotice of Annual General Meeting/Proxy Form
21/10/13		708.65KB	Share
IMUCeasing to be a substantial holder - JP
16/10/13		27.06KB	Share
IMUAnnual Report to shareholders
27/09/13		3.85MB	Share

REFRESH

First 7 8 9 10 11

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 26.5¢		Change -0.010(3.64%)		Mkt cap ! $76.45M

Open	High	Low	Value	Volume
27.0¢	27.5¢	26.0¢	$429.4K	1.618M

Buyers (Bids)

No.	Vol.	Price($)
17	433247	26.0¢

Sellers (Offers)

Price($)	Vol.	No.
26.5¢	28052	5

View Market Depth

No.	Vol.	Price($)
16	429401	0.260
18	332553	0.255
29	560028	0.250
10	87366	0.245
10	83374	0.240

Price($)	Vol.	No.
0.265	26303	2
0.270	23003	2
0.275	305890	9
0.280	122485	6
0.285	172137	7

Last trade - 16.10pm 08/08/2025 (20 minute delay)

IMU (ASX) Chart

IMUGENE LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available